Bardet-Biedl Syndrome Study: Clinical and Genetic Epidemiology Study in Adults
NCT ID: NCT00213811
Last Updated: 2008-08-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2003-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France
NCT02887781
Face Anthropometric Pattern Recognition Technology for Computer Aided Diagnosis of Human Genetic Disorders.
NCT00705055
Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome
NCT00482794
Natural History of Pompe Disease
NCT03564561
Vascular Abnormalities and Bleeding Diathesis
NCT04553172
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
clinical, biological, and radiological
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 3 of the five major criteria (retinitis pigmentosa, obesity, polydactyly, cognitive impairment, and kidney disorder) and/or BBS mutations identified
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hélène Dollfus, MD
Role: PRINCIPAL_INVESTIGATOR
Fédération Génétique
J-Louis Mandel, MD
Role: PRINCIPAL_INVESTIGATOR
IGBMC
Pascal Bousquet, MD
Role: PRINCIPAL_INVESTIGATOR
CIC Strasbourg
Christian Brandt, MD
Role: PRINCIPAL_INVESTIGATOR
CIC Strasbourg
Catherine Arnold, MD
Role: PRINCIPAL_INVESTIGATOR
CIC Strasbourg
Alain Verloes, MD
Role: PRINCIPAL_INVESTIGATOR
Unité de Génétique Robert Debré
Régis Hanfard, MD
Role: PRINCIPAL_INVESTIGATOR
CIC Robet Debré
Didier Lacombe, MD
Role: PRINCIPAL_INVESTIGATOR
Service de Génétique Médicale/Bordeaux
Virginie Bernard, MD
Role: PRINCIPAL_INVESTIGATOR
CIC Bordeaux
Sylvie Manouvrier, MD
Role: PRINCIPAL_INVESTIGATOR
Service de Génétique Médicale Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hélène Dollfus
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2899
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.